This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 TRTX
424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-226642 CALCULATION OF REGISTR
424B5 Table of Contents Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-226642 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying base prospectus are not an offe
Shares of CBRE Group Inc. (CBRE - Free Report) have gained 6.3% in the past three months compared with its industry’s growth of 5.2%. Further, the trend in current-year earnings estimate revisions indicates a solid outlook for the company. The fundamentals appear solid for this Zacks Rank #2 (Buy) stock and there are enough scope for its price appreciation in the near term. In fact, CBRE Group has a robust scale as the largest commercial real estate services and investment firm (based on 2017 revenues).
CBG TRTX CIG MMI CIGI CBRE
The following slide deck was published by TPG RE Finance Trust in conjunction with their 2018 Q2 earnings call.
TPG RE Finance Trust (TRTX - Free Report) just came out with quarterly earnings of $0.44 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.64 per share a year ago. These figures are adjusted for non-recurring items.
APLE AMT TRTX TCMD GTLS BWXT
trtx-8k_20180806.htm UNITED STATES
trtx-10q_20180630.htm UNITED STATES
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
ECOR PLNT PKG AEP NINE ADT GE COF-P GILD TMUS PDYPF SYF XERS JNJ VZ MSFT ADS KZR NNN EIDX FB AVRO HOPE NFLX AXP EHC BAC COF-D SEAS COF-C COF-F KR KS IIIV PNFP AAPL DDOC SJM INPAP SIX JPM GNE WRK LGEJY KMRFZ DE 39IB KMX RF UAL WMT CFIN LGEAF IP AMZN MGTA NTRS HON KMI CIWV HCSG KMR CVB VLKAY LGEIY EBAY EPRT STT SLB BAC DFS LGEPF STM BBY BX BK STM LTXB LGLD SLB FOXA CLW PM NTRSP AUTL DLPH SWKS GS SWK TRTX GM PII DIS NEE IBM MOR F GEC C CMCSA COF FUN FUL CFG HBAN XEL TGT BLK S PPG T SNE DPZ
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
XKE BPY VNO VNO.WI VNORP CXP TRTX NYRT
The July 2018 REML dividend will bring, on a monthly compounded annualized rate, its yield to 22.2%.
SLDA STAR ANH ORC MITT BAC REM LADR TRTX CMO KREF AGNC RWT GPMT ABR GE GEC CEFL HOG ARR XAN SLD GNE
trtx-8k_20180615.htm UNITED STATES
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...
as of ET